ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

ClinicalTrials.gov ID: NCT06307626

Public ClinicalTrials.gov record NCT06307626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 4:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease

Study identification

NCT ID
NCT06307626
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
argenx
Industry
Enrollment
105 participants

Conditions and interventions

Interventions

  • Efgartigimod PH20 SC Combination Product
  • Placebo PH20 SC Other

Combination Product · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2024
Primary completion
Dec 14, 2025
Completion
Feb 11, 2026
Last update posted
Mar 15, 2026

2024 – 2026

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
11
Facility City State ZIP Site status
American Institute of Research Los Angeles California 90017
North Valley Eye Medical Group, Inc. Mission Hills California 91345
Martel Eye Medical Group Rancho Cordova California 95670
Cockerham Eye Consultants San Diego California 91208
Sibia Eye Institute Boynton Beach Florida 33437
Sarasota Retina Institute (SRI) Sarasota Florida 34239
Butchertown Clinical Trials Louisville Kentucky 40206
St. Louis University (SLU) Care - Center for Specialized Medicine St Louis Missouri 63104
Advancing Research International, LLC Las Vegas Nevada 89144
New York Eye & Ear Infirmary New York New York 10003
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06307626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06307626 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →